|
| Press Releases |
|
 |
|
| Monday, July 27, 2020 |
|
|
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM |
| Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focusing on the development of novel therapeutics to address global unmet medical needs more info >> |
|
| Monday, March 30, 2020 |
|
|
知临集团与Covar医疗携手依托现有Smart-ACTTM平台和Acticule传染病平台研究至少3种2019冠状病毒肺炎(COVID-19)候选再利用药物（SACT-COV19） |
| 致力于开发创新疗法以解决传染病、孤儿病及代谢性疾病等全球未被满足的医疗需求的生物制药公司知临集团（纳斯达克股票代码：APM），今日宣布额外启动一针对各种冠状病毒的研究和开发项目，并已在药物再利用和新药发现平台Smart-ACTTM中完成初步筛选 more info >> |
|
|
知臨集團與Covar醫療攜手依託現有Smart-ACTTM平台和Acticule傳染病平台研究至少3種2019冠狀病毒肺炎(COVID-19)候選再利用藥物（SACT-COV19） |
| 致力於開發創新療法以解決傳染病、孤兒病及代謝性疾病等全球未被滿足的醫療需求的生物製藥公司知臨集團（納斯達克股票代碼：APM），今日宣佈額外啟動一針對各種冠狀病毒的研究和開發項目，並已在藥物再利用和新藥發現平台Smart-ACTTM中完成初步篩選 more info >> |
|
|
Aptorum Group Collaborates with Covar Pharmaceuticals to Investigate 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT Platform and Acticule Infectious Disease Platform |
| Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas more info >> |
|
|
知临集团将举行2020年第一季度投资者跟进电话会议以讨论最新进展和产品线进度 |
| 致力于开发创新疗法以满足全球未被满足的医疗需求的生物制药公司知临集团（纳斯达克股票代码：APM），今日就世界卫生组织于2020年3月11日宣布冠状病毒大爆发为全球大流行性疾病，提供公司营运的最新信息。 more info >> |
|
|
知臨集團將舉行2020年第一季度投資者跟進電話會議以討論最新進展和產品線進度 |
| 致力於開發創新療法以滿足全球未被滿足的醫療需求的生物製藥公司知臨集團（納斯達克股票代碼：APM），今日就世界衛生組織於2020年3月11日宣佈冠狀病毒大爆發為全球大流行性疾病，提供公司營運的最新資訊。 more info >> |
|
|
Aptorum Group Limited Corporate Update and To Hold Q1 2020 Investor Update Call To Discuss Recent Development and Pipeline Progress |
| Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today provides an update on the Company's operations in light of the recent declaration of the coronavirus outbreak as a pandemic declared by the World Health Organisation on March 11, 2020. more info >> |
|
| Monday, February 24, 2020 |
|
|
知临集团开始商业化山药生物活性营养片剂并在香港签署销售分销协议 |
| 致力于开发创新疗法以解决全球未被满足的医疗需求的生物制药公司知临集团 （纳斯达克股票代码：APM），公布商业化其膳食补充剂，该产品适用于伴有症状的更年期女性。 more info >> |
|
|
知臨集團開始商業化山藥生物活性營養片劑並在香港簽署銷售分銷協議 |
| 致力於開發創新療法以解決全球未被滿足的醫療需求的生物製藥公司知臨集團 （納斯達克股票代碼：APM），公佈商業化其膳食補充劑，該產品適用於伴有症狀的更年期女性。 more info >> |
|
|
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong |
| Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the commercialization of its dietary supplement for women undergoing menopause and experiencing related symptoms. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development
Nov 22, 2024 23:22 HKT/SGT
|
|
|
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results
Nov 22, 2024 19:56 HKT/SGT
|
|
|
达丰设备服务有限公司 公布2024/25中期业绩
Nov 22, 2024 19:35 HKT/SGT
|
|
|
達豐設備服務有限公司 公佈2024/25中期業績
Nov 22, 2024 19:18 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 22, 2024 14:42 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 22, 2024 14:41 HKT/SGT
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 12:00: JST
|
|
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
アレス・マネジメント、東京オフィス開設でアジア事業を拡充
Nov 22, 2024 09:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
